Back to Top

There is a Mary Ann Liebert at Mary Ann Liebert, Inc. and that makes a difference.

For Immediate Release

Controversies and Consensus in Thyroid Cancer Care

Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com

New Rochelle, NY, June 24, 2021—The American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and Molecular Imaging released a joint statement on three key topics addressing controversies in thyroid cancer care. The joint statement is published in the peer-reviewed journal Thyroid®, the official journal of the American Thyroid Association® (ATA®).Click here to read the statement now.

An inter-societal working group addressed the current controversies and evolving concepts in three main areas: peri-operative risk stratification; the role of diagnostic radioactive iodine (RAI) imaging in initial staging; and indicators of response to RAI therapy. They reached several conclusions that are detailed in the joint statement, led by Seza Gulec, MD, Florida International University Herbert Wertheim College of Medicine, and coauthors. For peri-operative risk stratification, the working group concluded that this should include “judicious incorporation of molecular theranostics to further refine management recommendations.”

“The article provides a useful update on thyroid cancer management issues through a truly collaborative effort from leading societies across the globe,” says Electron Kebebew, MD, FACS, Editor-in-Chief of Thyroid, Professor of Surgery, Chief, Division of General Surgery, Harry A. Oberhelman and Mark L. Welton Professor, Stanford University School of Medicine (Stanford, CA).

About the Journal
Thyroid®, the official journal of the American Thyroid Association®, (ATA®) is an authoritative peer-reviewed journal published monthly online with open access options and in print. The Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. Complete tables of content and a sample issue may be viewed on the Thyroid website. The complete Thyroid Journal Program includes the highly valued abstract and commentary publication Clinical Thyroidology®, led by Editor-in-Chief Angela Leung, MD and published monthly, and the groundbreaking videojournal companion VideoEndocrinology, led by Editor William Barry Inabnet, III, MD and published quarterly. Complete tables of content and sample issues may be viewed on the Thyroid website.

About the American Thyroid Association®
The?American Thyroid Association® (ATA) is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery and advocacy in a collaborative and diverse community. ATA® is an international professional medical society with over 1,800 members from 43 countries around the world. The ATA® promotes thyroid awareness and information through Clinical?Thyroidology® for the Public, a resource that summarizes research for patients and families, and extensive, authoritative resources on thyroid disease and thyroid cancer in both English and Spanish. The ATA® website?www.thyroid.org?serves as a?bonafide?clinical resource for patients and the public who look for reliable thyroid-related information.? 

About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. A complete list of the firm’s more than 100 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com